Literature DB >> 22498443

Multimodality imaging of ureteric disease.

Puneet Bhargava1, Manjiri K Dighe, Jean Hwa Lee, Carolyn Wang.   

Abstract

The proximal ureter (upper) extends from the ureteropelvic junction to where the ureter crosses the sacroiliac joint, the middle ureter courses over the bony pelvis and iliac vessels, and the distal or pelvic (lower) ureter extends from the iliac vessels to the bladder. Benign and malignant lesions can affect the ureter and these may be caused by contiguous involvement from the kidney or bladder. The ureter can be imaged by computed tomography; magnetic resonance imaging; direct pyelography, both antegrade and retrograde; nuclear medicine diuretic scan; and voiding cystourethrography. This article discusses benign, malignant, neoplastic, nonneoplastic processes involving the ureter. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22498443     DOI: 10.1016/j.rcl.2012.02.008

Source DB:  PubMed          Journal:  Radiol Clin North Am        ISSN: 0033-8389            Impact factor:   2.303


  3 in total

Review 1.  Multi-modality imaging of the leaking ureter: why does detection of traumatic and iatrogenic ureteral injuries remain a challenge?

Authors:  Abdullah Alabousi; Michael N Patlas; Christine O Menias; David Dreizin; Sanjeev Bhalla; Man Hon; Andres O'Brien; Douglas S Katz
Journal:  Emerg Radiol       Date:  2017-04-27

2.  Polyuria due to vasopressin V2 receptor antagonism is not associated with increased ureter diameter in ADPKD patients.

Authors:  Niek F Casteleijn; A Lianne Messchendorp; Kyong T Bae; Eiji Higashihara; Peter Kappert; Vicente Torres; Esther Meijer; Anna M Leliveld
Journal:  Clin Exp Nephrol       Date:  2016-06-23       Impact factor: 2.801

3.  Urologic manifestations of inflammatory pseudotumor: Report of 2 cases and review of the literature.

Authors:  Nitin P Ghonge; Disha Mittal; Sudhir Jain; Bharat Aggarwal; Mariam Moshiri; Chandana Lall; Puneet Bhargava
Journal:  Radiol Case Rep       Date:  2015-12-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.